InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
1
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-7.6%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the detailed record of transactions filed by Lynch Karen S, 首席执行官. Insider active across 4 companies, notably CVS HEALTH Corp. Cumulatively, 13 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €882k. Activity tracked since 28 November 2021. The latest transaction was disclosed on 12 November 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Lynch Karen S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
1,453 股0Common StockSEC:0001225208-25-009210:0
565 股0Common StockSEC:0000097745-25-000057:0
95 股0Common StockSEC:0001127602-25-006219:0
45,248 股@ US$79.5614.2% 占其流量Common Stock (Restricted)SEC:0001127602-24-012256:0
136,640 股0Common StockSEC:0001127602-24-005068:0
14,000 股@ US$69.75483.7% 占其流量Common Stock (By Trust)SEC:0001127602-23-014615:0
标准退出：2023年8月1日 (T+90)
93,677 股@ US$74.3127.0% 占其流量Common StockSEC:0001127602-23-012242:0
206,610 股0Common StockSEC:0001127602-23-003331:0
116,940 股@ US$101.0947.6% 占其流量Common StockSEC:0001127602-22-011633:0
257,916 股0Common StockSEC:0001127602-22-006296:0
14,121 股@ US$91.525.1% 占其流量Common StockSEC:0001127602-21-029913:0
40,500 股Common StockSEC:0001122304-16-000193:0
18,024 股Common StockSEC:0001122304-16-000193:1
13 条申报中的 13 条
About Lynch Karen S
Lynch Karen S is Président et Directeur Général. She has 13 filings in total, and across the 13 sampled filings, the attribution and buy amounts run from 2016-02-03 to 2025-11-14, with sum_buy_eur at 882260 and sum_sell_eur at 0. She is also linked to CVS HEALTH Corp as President and CEO, to Thermo Fisher Scientific INC. as Director, to AETNA INC /PA/ as President, and to Automatic Data Processing INC as Director.
